moderna emergency use authorization

News

Moderna, FDA and COVID

Moderna gets full US approval for COVID vaccine in children 6 months and older

The U.S. Food and Drug Administration has granted full approval for Moderna's COVID-19 vaccine, Spikevax, in children aged 6 months through 11 years who are at an increased risk of the disease, the company said on Thursday.

· 2d

Moderna COVID vaccine gets FDA green light for kids 6 months to 11 years

STAT · 2d

FDA grants full approval to Moderna’s Covid vaccine for children but limits eligibility

ABC7 San Francisco2d

Moderna seeks emergency use authorization for Covid-19 vaccine for ...

NEW YORK -- Moderna is seeking emergency use authorization from the US Food and Drug Administration for its Covid-19 vaccine for children 6 months through 5 years of age, the company said ...

StockStory.org on MSN3d

Why Moderna (MRNA) Stock Is Up Today

Shares of biotechnology company Moderna (NASDAQ:MRNA) jumped 3.8% in the morning session after the U.S. Food and Drug ...

Results that may be inaccessible to you are currently showing.

Hide inaccessible results

News

Moderna, FDA and COVID

Trending now